-
Product Insights
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2022, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape. Endometrial cancer is cancer that starts in the endometrium, the lining of the uterus (womb). Endometrial cancer is the most common type of uterine cancer. Although the exact cause of endometrial cancer is unknown, increased levels of estrogen appear to play a role. Estrogen helps stimulate the buildup of the lining of the...
-
Product Insights
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Vaginal cancer is rare cancer that occurs in the vagina. Its symptoms include watery vaginal discharge, a lump or mass in the vagina, painful urination, constipation, and pelvic pain, vaginal bleeding. The Vaginal Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Vaginal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics,...
-
Product Insights
Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Post-Polycythemia Vera Myelofibrosis (PPV-MF) is a myeloproliferative blood cancer in which the bone marrow makes too many red blood cells. Symptoms include heart attack, stroke, deep venous thrombosis, headaches, lack of concentration, and fatigue. The Post-Polycythemia Vera Myelofibrosis (PPV-MF) pipeline drugs market research report provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology), complete with analysis by stage of development, drug...
-
Product Insights
Oligodendroglioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The most common symptoms of Oligodendroglioma are seizures, headaches, and personality changes. Treatment includes chemotherapy surgery and radiation therapy. The Oligodendroglioma pipeline drugs market research report provides an overview of the Oligodendroglioma (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oligodendroglioma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Esophageal cancer symptoms include cough, difficulty swallowing, chest pain, pressure or burning, and weight loss. Predisposing factors include age, smoking, obesity, and bile reflux. Treatment includes chemotherapy, radiation therapy, and surgery. The Esophageal Cancer pipeline drugs market research report provides an overview of the Esophageal Cancer (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Esophageal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA),...
-
Product Insights
Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Risk factors of Human Papillomavirus (HPV) Associated Cancer includes smoking, weakened immune system, long-term oral contraceptive use, and chronic inflammation. The Human Papillomavirus (HPV) Associated Cancer pipeline drugs market research report provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Papillomavirus (HPV) Associated Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Uveal melanoma symptoms include dark spot on the iris, glaucoma, eye pain, and eye redness. Treatment for the disease includes surgery, radiation, and proton therapy. The Uveal Melanoma pipeline drugs market research report provides an overview of the Uveal Melanoma (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uveal Melanoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also...
-
Product Insights
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peritoneal cancer develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus, and extends over the bladder and rectum. Peritoneal cancer usually manifests with abdominal distention and diffuse nonspecific abdominal pain secondary to ascites. Peritoneal cancer symptoms may include shortness of breath, rectal bleeding, loss of appetite, frequent urination, constipation, nausea or diarrhea, and feeling of fullness, even after a light meal. Treatment includes options such as chemotherapy, surgery, biological...
-
Product Insights
Rhabdomyosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Rhabdomyosarcoma (RMS) is a malignant tumor of connective tissue in which abnormal cells are thought to arise from primitive muscle cells. Symptoms include pain, fever, purplish discoloration of the eye, hearing loss, headaches, bulging of the eye, or a droopy eyelid, and tingling or weakness. Predisposing factors include age, inherited conditions (neurofibromatosis type 1, Costello syndrome), and family history. Treatment includes surgery, chemotherapy, and radiation therapy. The Rhabdomyosarcoma pipeline drugs market research report provides an overview of the Rhabdomyosarcoma (Oncology)...
-
Product Insights
Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Metastatic Biliary Tract Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Metastatic Biliary Tract Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.